2Edwards JI. Diagnosis and management of benign prostatic hyperplasia[J].Am Faro Physician, 2008, 77(10): 1403-1410.
3Kaplan SA, McConnell JD, Roehrborn CG, et al. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater[J].J Urol, 2006, 175(1):217-220.
4Shih HJ, Chow YC, Huang CJ, et al. Catheter-assisted transurethral resection of the prostate: a novel approach[J]. Urol Int, 2008, 80(4):383-388.
二级参考文献5
1Mary MC,Michael JB.Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.Am J Med,2005,118:1331-1339.
2American Urological Association Practice Guidelines Committee.American Urological Association guideline on management of benign prostatic hyperplasia (2003).Chapter 1.Diagnosis and treatment recommendations.J Urol,2003,170:530-547.
3Roehrborn CG,Boyle P,Nichol JC,et al.Efficacy and safety of a dual inhibitor of 5-alpha reductase types 1 and 2(dutasteride) in men with benign prostatic hyperplasia.Urology,2002,60:434-441.
4Lepor H,Williford WO,Barry MJ,et al.The efficacy of terazosin,finasteride,or both in benign prostatic hyperplasia.Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.N Engl J Med,1996,335:533-539.
5McConnell JD,Roehrbom CG,Bautista OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia.N Engl J Med,2003,349:2387-2398.
